SNCA and synucleinopathy: However, attempts to develop vaccines for PD and other synucleinopathies have failed because most studies have used the native form of alpha‐synuclein rather than its amyloid form, which the immune system is unable to distinguish from the pathological form.33, 34, 35, 36, 37, 38, 39